MedTrace Logo

State of the Art Immediate Implant Placement in the Premaxilla

NCT07080710 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2025-11-18

No results posted yet for this study

Summary

The goal of this clinical study is to learn how well immediate implant placement works in the front upper jaw (premaxilla) when using flapless guided surgery, hard and soft tissue augmentation, and immediate provisional crowns. It will also learn about the safety and esthetic results of this treatment approach.

The main questions it aims to answer are:

Primary:

How much buccal bone thickness remains one year after implant placement 1mm below the implant shoulder?

Secondary:

* How do patients rate pain, healing, and esthetics after treatment?
* Are there any complications over the course of five years?
* How much buccal bone thickness remains one year after implant placement 3mm and 5mm below the implant shoulder?
* Marginal bone loss at one-year and five-year follow-up?
* Peri-implant health at one-year and five-year follow-up?
* Soft tissue changes at one-year and five-year follow-up?

Researchers will compare treatment results in patients with intact bone sockets to those with damaged (non-intact) sockets.

Participants will:

* Receive a dental implant and temporary crown on the same day as the tooth extraction
* Undergo guided, flapless surgery with bone and soft tissue grafting
* Take antibiotics and anti-inflammatories for 4 days after surgery
* Visit the clinic at 1 week, 3 months, 1 year, and 5 years for follow-up exams
* Have X-rays, digital scans, and photos taken to measure bone and soft tissue changes
* Answer questions about pain and esthetic satisfaction

Conditions

  • Bone Resorption

Interventions

PROCEDURE

Immediate implant placement

Immediate implant placement with socket grafting and soft tissue augmentation. In cases with a buccal dehiscence \>3mm only this technique is applied. In cases with a buccal dehiscence between 4-6mm a collagen membrane is applied prior to socket grafting. In cases with a buccal dehiscence \> 6 mm, a collagen membrane is also applied and a mixture of C-DBBM and autogenous bone chips (1:1 ratio) is used as grafting material.

Sponsors & Collaborators

  • University Ghent

    lead OTHER

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-07-01
Primary Completion
2027-02-01
Completion
2032-02-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07080710 on ClinicalTrials.gov